ID   HX155cisR
AC   CVCL_M691
SY   HX/155cisR
DR   Wikidata; Q54896982
RX   PubMed=8347478;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_L442 ! HX155c
SX   Female
AG   44Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 10
//
RX   PubMed=8347478; DOI=10.1038/bjc.1993.322; PMCID=PMC1968570;
RA   Mellish K.J., Kelland L.R., Harrap K.R.;
RT   "In vitro platinum drug chemosensitivity of human cervical squamous
RT   cell carcinoma cell lines with intrinsic and acquired resistance to
RT   cisplatin.";
RL   Br. J. Cancer 68:240-250(1993).
//